Ilaria Bersani

An Expanded Peripheral T Cell Population to a Cytotoxic T Lymphocyte (Ctl)-Defined, Melanocyte-Specific Antigen in Metastatic Melanoma Patients Impacts on Generation of Peptide-Specific Ctls but Does Not Overcome Tumor Escape from Immune Surveillance in Metastatic Lesions

Andrea Anichini, Alessandra Molla, Roberta Mortarini et al. · The Journal of Experimental Medicine · 1999 · 191 citations · Full text

Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.

Roberta Mortarini, Adriano Piris, Andrea Maurichi et al. · PubMed · 2003 · 178 citations

Immunology, Immunoediting, Antitumor Immunity +16

Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma

Marialuisa Sensi, Gabriella Nicolini, Carlotta Petti et al. · Oncogene · 2006 · 176 citations

Medicine, Exclusive Nrasq61r, Melanoma +9

Human Cutaneous Melanomas Lacking MITF and Melanocyte Differentiation Antigens Express a Functional Axl Receptor Kinase

Marialuisa Sensi, Mara Catani, Giancarlo Castellano et al. · Journal of Investigative Dermatology · 2011 · 141 citations · Full text

Signal Transduction, Cutaneous Biology, Melanoma +9

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

Lorenzo Pilla, Roberto Patuzzo, Licia Rivoltini et al. · Cancer Immunology Immunotherapy · 2005 · 137 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Phase Ii Trial +13